Correspondence regarding “Assessment: Botulinum Neurotoxin in the Treatment of Autonomic Disorders and Pain (An Evidence-Based Review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology”
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.